aeruginosa—one of the most prevalent infection-causing bacteria in cystic fibrosis—and evidence of phage-resistant bacteria having reduced pathogenicity in the nine adults treated with this ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Lambda, the AI Developer Cloud, today announced it has raised a $480 million Series D, bringing the total equity capital raised to date to $863 million.

In 1919, microbiologist Felix d’Hérelle, a co-discoverer of phages, participated in the administration of what was probably the first phage therapy. 1 It was received by a 12-year-old boy who ...

To optimize phage therapy and make it scalable to human disease, scientists need ways to engineer phages into efficient bacteria-killing machines. This would also offer an alternative way to treat ...

Results from a new study are providing new insights into the therapeutic potential of bacteriophage (phage) therapy for treating diseases like cystic fibrosis (CF). Results from a new Dartmouth ...

April 4 (Reuters) - Lambda has secured a $500 million loan from lenders including Macquarie Group (MQG.AX), opens new tab with Nvidia's (NVDA.O), opens new tab much-coveted chips as collateral ...

With her family on board and “compassionate use” approval obtained from the Food and Drug Administration, doctors at the University of Pittsburgh School of Medicine administered the phage therapy.

Riding high on the AI hype cycle, Lambda – formerly known as Lambda Labs and well known to readers of The Next Platform – has received a $320 million cash infusion to expand its GPU cloud to support ...

If you’re a Java developer and you haven’t built an AWS Lambda function before, you’ll be amazed by how easy it is to get your first serverless application up and running. To build your first Java AWS ...